1-1 of 1
Bruce A. Wallin, MD
Close
Sort by
Journal Articles

NE-180, a Novel glycoPEGylated Erythropoietin Demonstrates Dose-Dependent Activity in a Phase 1 Single Dose, Dose Escalating Study in Normal Human Volunteers (NHV).

Bruce A. Wallin, MD, Denise Ramjit, Michael Seiberling, MD, David Zopf, MD
Journal: Blood
Blood (2006) 108 (11): 1149.
https://doi.org/10.1182/blood.V108.11.1149.1149
Published: 2006